Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2010
01/06/2010CN100577643C Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
01/06/2010CN100577163C Compounds effecting glucokinase
01/06/2010CN100577162C Substituted oxazolidinones for combinational therapy
01/05/2010US7642358 Antidiabetic agents; modulate insulin drug resistance
01/05/2010US7642354 Polycyclic pyrazines as potassium ion channel modulators
01/05/2010US7642351 2,4-Pyrimidinediamine compounds and their uses
01/05/2010US7642280 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
01/05/2010US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis
01/05/2010US7642274 (+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)propoxy)-5-methoxyphenyl]benzothiazoline; kappa -opioid receptor agonist
01/05/2010US7642267 Benzimidazole and pyridylimidazole derivatives
01/05/2010US7642260 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide
01/05/2010US7642255 Compounds and compositions as protein kinase inhibitors
01/05/2010US7642254 ATM inhibitors
01/05/2010CA2545999C 1,2-di(cyclic)substituted benzene compounds
01/05/2010CA2539176C Process for the preparation of chiral propionic acid derivatives
01/05/2010CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
01/05/2010CA2392081C Pharmaceutically active isoindoline derivatives
01/05/2010CA2390100C Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
01/05/2010CA2318889C Insecticidal dihydro-oxadiazines, -thiadiazines and -triazines
01/05/2010CA2318192C .beta.2-adrenergic receptor agonists
01/05/2010CA2185397C Arylalkyl-diazinones
12/2009
12/31/2009US20090326238 Asymmetric dendrimers
12/31/2009US20090326223 Synthesis of 2-amino-substituted 4-oxo-4h-chromen-8.yl-trifluoro-methanesulfonic acid esters
12/31/2009US20090326222 Benzothiazole cyclobutyl amine derivatives
12/31/2009US20090326220 Tetrazole-Substituted Arylamides as P2X3 and P2X2/3 Antagonists
12/31/2009US20090326201 Affinity Adsorbents for Fibrinogen
12/31/2009US20090326016 Fungicidal n-cycloalkyl-carboxamide derivatives
12/31/2009US20090326011 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators
12/31/2009US20090325957 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
12/31/2009US20090325956 Aromatic amine derivative and use thereof
12/31/2009US20090325955 Gyrase inhibitors and uses thereof
12/31/2009US20090325954 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
12/31/2009US20090325951 Thienyl-and furanyl-isoquinolinones and methods for using them
12/31/2009US20090325950 Benzoxazine derivatives and uses thereof
12/31/2009US20090325948 Inhibitors of undecaprenyl pyrophosphate synthase
12/31/2009US20090325947 Nitrate esters of piperidines
12/31/2009US20090325946 Novel phenolic and catecholic amines and prodrugs thereof
12/31/2009US20090325935 Gyrase inhibitors and uses thereof
12/31/2009US20090325932 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
12/31/2009US20090325926 Pyrrolo[3,2-d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
12/31/2009US20090325925 Thiophenes and uses thereof
12/31/2009US20090325924 GPCR Agonists
12/31/2009US20090324581 Heteroarylamide lower carboxylic acid derivative
12/31/2009US20090324569 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
12/31/2009US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate
12/31/2009US20090324544 Substituted cyclic pyrrolidine derivatives
12/31/2009US20090324543 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
12/30/2009WO2009158571A1 Heteroaryl compounds and uses thereof
12/30/2009WO2009158473A1 5- and 6-membered heterocyclic compounds
12/30/2009WO2009158467A2 Di-substituted phenyl compounds
12/30/2009WO2009158393A1 1, 2 disubstituted heterocyclic compounds
12/30/2009WO2009158258A1 Herbicidal dihydro oxo six-membered azinyl isoxazolines
12/30/2009WO2009158011A1 Alkynyl alcohols as kinase inhibitors
12/30/2009WO2009157860A1 New heterocyclic carboxamides for use as thrombin inhibitors
12/30/2009WO2009156484A2 Organic compounds
12/30/2009WO2009156462A2 Organic compounds
12/30/2009WO2009156421A1 Squaric acid derivatives as inhibitors of the nicotinamide
12/30/2009WO2009156339A1 Isoquinolinone derivatives as nk3 antagonists
12/30/2009WO2009156284A1 Novel substituted pyridin-2-ones and pyridazin-3-ones
12/30/2009WO2009136995A3 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/30/2009WO2009131957A8 Compounds, compositions and methods comprising oxadiazole derivatives
12/30/2009WO2009125940A3 Photoactive compound and photosensitive resin composition comprising the same
12/30/2009WO2009106708A3 Azetidine derivatives, their preparation and their application in therapy
12/30/2009WO2008142623A3 Tumor necrosis factor - alpha inhibitors
12/30/2009EP2138487A1 Substituted morpholine and thiomorpholine derivatives for the treatment of bipolar disorders
12/30/2009EP2138486A1 Compound for organic electroluminescent device and organic electroluminescent device
12/30/2009EP2138482A1 Bicyclic heterocyclic compound
12/30/2009EP1805202B1 Conjugates with anti-inflammatory activity
12/30/2009EP1620395B1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
12/30/2009EP1608632B1 Quinazolines useful as modulators of ion channels
12/30/2009EP1501812B1 Pna monomer and precursor
12/30/2009CN101616915A Composition and methods for modulating a kinase cascade
12/30/2009CN101616914A Indole derivatives
12/30/2009CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/30/2009CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
12/30/2009CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009CA2729546A1 Compounds and compositions as kinase inhibitors
12/30/2009CA2729327A1 Organic compounds
12/30/2009CA2729275A1 5- and 6-membered heterocyclic compounds
12/30/2009CA2729259A1 1,2-disubstituted heterocyclic compounds
12/30/2009CA2729220A1 Di-substituted phenyl compounds
12/30/2009CA2729108A1 Organic compounds
12/30/2009CA2728806A1 Squaric acid derivatives as inhibitors of the nicotinamide phosphoribosyltransferase
12/30/2009CA2728767A1 Alkynyl alcohols as kinase inhibitors
12/30/2009CA2728283A1 Isoquinolinone derivatives as nk3 antagonists
12/30/2009CA2728016A1 Novel substituted pyridin-2-ones and pyridazin-3-ones
12/30/2009CA2727925A1 New heterocyclic carboxamides for use as thrombin inhibitors
12/30/2009CA2727455A1 Heteroaryl compounds and uses thereof
12/29/2009US7638632 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties
12/29/2009US7638631 Methylene dipiperidine derivatives
12/29/2009US7638546 Imidazolyl derivatives
12/29/2009US7638540 Benzofuran compound and medicinal composition containing the same
12/29/2009US7638539 5-(4-{2-[5-methyl-2-(4-trifluoromethyl-phenyl)-thiazol -4-yl]-ethoxy}-phenyl)-3H-[1,3,4] oxadiazol-2-one; treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization such as multiple scleroses
12/29/2009US7638537 Pyrazole compounds as transforming growth factor (TGF) inhibitors
12/29/2009US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009CA2524043C 1-(2h-pyrazol-3-yl)-3-{4-'1-(benzoyl)-piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/29/2009CA2478799C Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/29/2009CA2424522C Substituted benzene derivatives or salts thereof
12/29/2009CA2345369C Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
12/29/2009CA2338543C Method of direct identification of compound efficacy at a g protein-coupled orphan receptor
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 647